CACamila F. Almeida

Camila F. Almeida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Camila F. Almeida has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Mariz Vainzof

    Human Genome and Stem Cells Research Center, Institute of Biosciences, University of São Paulo, São Paulo 05508-090, SP, Brazil

    2 shared publications
  • Alex Brinkman

    Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA

    1 shared publication
  • Alice Rannou

    Nantes Université, CHU de Nantes, INSERM, TaRGeT-Translational Research in Gene Therapy, UMR 1089, F-44200, Nantes, France

    1 shared publication
  • Anne Bigot

    Sorbonne Université, Inserm, Institut de Myologie, Centre de Recherche en Myologie, Paris, France

    1 shared publication
  • Chaitrali Atre

    Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA

    1 shared publication
  • Courtney S. Young

    MyoGene Bio, 7098 Miratech Dr Suite 120 San Diego, 92121, USA

    1 shared publication

Latest Publications

  • Open Access

    Histological, functional, and behavioral comparison of three Duchenne muscular dystrophy mouse models

    by Dhanarajan Rajakumar, Camila F. Almeida, Alex Brinkman, Ding Li, Alice Rannou, Chaitrali Atre, Tatyana A. Vetter, Courtney S. Young, Kevin Flanigan, Melissa J. Spencer, et al.

  • Satellite cells deficiency and defective regeneration in dynamin 2‐related centronuclear myopathy

    by Camila F. Almeida, Marc Bitoun, Mariz Vainzof

    Dynamin 2 (DNM2) is a ubiquitously expressed protein involved in many functions related to trafficking and remodeling of membranes and cytoskeleton dynamics. Mutations in the DNM2 gene cause the autosomal dominant centronuclear myopathy (AD‐CNM), characterized mainly by muscle weakness and central nuclei. Several defects have been identified in the KI‐ Dnm2 R465W/+ mouse model of the disease to explain the muscle phenotype, including reduction of the satellite cell pool in muscle, but the functional consequences of this depletion have not been characterized until now. Satellite cells (SC) are the main source for muscle growth and regeneration of mature tissue. Here, we investigated muscle regeneration in the KI‐ Dnm2 R465W/+ mouse model for AD‐CNM. We found a reduced number of Pax7‐positive SCs, which were also less activated after induced muscle injury. The muscles of the KI‐ Dnm2 R465W/+ mouse regenerated more slowly and less efficiently than wild‐type ones, formed fewer new myofibers, and did not recover its normal mass 15 days after injury. Altogether, our data provide evidence that the muscle regeneration is impaired in the KI‐ Dnm2 R465W/+ mouse and contribute with one more layer to the comprehension of the disease, by identifying a new pathomechanism linked to DNM2 mutations which may be involved in the muscle‐specific impact occurring in AD‐CNM.


  • Open Access

    Altered in vitro muscle differentiation in X-linked myopathy with excessive autophagy

    by Stephanie A. Fernandes, Camila F. Almeida, Lucas S. Souza, Monize Lazar, Paula Onofre-Oliveira, Guilherme L. Yamamoto, Letícia Nogueira, Letícia Y. Tasaki, Rafaela R. Cardoso, Rita C. M. Pavanello, et al.

    X-linked myopathy with excessive autophagy (XMEA) is a genetic disease associated with weakness of the proximal muscles. It is caused by mutations in the VMA21 gene, coding for a chaperone that functions in the vacuolar ATPase (v-ATPase) assembly. Mutations associated with lower content of assembled v-ATPases lead to an increase in lysosomal pH, culminating in partial blockage of macroautophagy, with accumulation of vacuoles of undigested content. Here, we studied a 5-year-old boy affected by XMEA, caused by a small indel in the VMA21 gene. Detection of sarcoplasmic Lc3 (also known as MAP1LC3B)-positive vacuoles in his muscle biopsy confirmed an autophagy defect. To understand how autophagy is regulated in XMEA myogenesis, we used patient-derived muscle cells to evaluate autophagy during in vitro muscle differentiation. An increase in lysosomal pH was observed in the patient's cells, compatible with predicted functional defect of his mutation. Additionally, there was an increase in autophagic flux in XMEA myotubes. Interestingly, we observed that differentiation of XMEA myoblasts was altered, with increased myotube formation observed through a higher fusion index, which was not dependent on lysosomal acidification. Moreover, no variation in the expression of myogenic factors nor the presence of regenerating fibers in the patient's muscle were observed. Myoblast fusion is a tightly regulated process; therefore, the uncontrolled fusion of XMEA myoblasts might generate cells that are not as functional as normal muscle cells. Our data provide new evidence on the reason for predominant muscle involvement in the context of the XMEA phenotype. This article has an associated First Person interview with the first author of the paper.